Nasopharyngeal carcinoma. IV. Evolution of complement-fixing antibodies during the course of the disease.
D000914:Antibodies, Viral / Q000032:analysis*; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D000956:Antigens, Viral / Q000032:analysis; D002051:Burkitt Lymphoma / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000532:radiotherapy; D002460:Cell Line; D003168:Complement Fixation Tests; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D008297:Male; D009303:Nasopharyngeal Neoplasms / Q000276:immunology* / Q000532:radiotherapy; D013997:Time Factors
D000914:Antibodies, Viral; D000956:Antigens, Viral